Investigating the correlation between small molecular inhibitor utilization, peripheral blood monocytes, and treatment outcomes in Rosai Dorfman disease-Reference-Cited by-同舟云学术

Investigating the correlation between small molecular inhibitor utilization, peripheral blood monocytes, and treatment outcomes in Rosai Dorfman disease

Published:2023-11-09 Issue:1 Volume:103 Page:37-59
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Reynolds Samuel B.^ORCID,Wilcox Sabrina,Li Qing,Ahmed Asra Z.

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00277-023-05494-x.pdf

Reference15 articles.

1. Abla O, Jacobsen E, Picarsic J, Krenova Z, Jaffe R, Emile JF et al (2018) Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease. Blood 131(26):2877–2890

2. Salama HA, Jazieh AR, Alhejazi AY, Absi A, Alshieban S, Alzahrani M et al (2021) Highlights of the Management of adult histiocytic disorders: Langerhans cell histiocytosis, Erdheim-Chester disease, Rosai-Dorfman disease, and hemophagocytic lymphohistiocytosis. Clin Lymphoma Myeloma Leuk 21(1):e66–e75

3. Aaroe A, Kurzrock R, Goyal G, Goodman AM, Patel H, Ruan G et al (2023) Successful treatment of non-Langerhans cell histiocytosis with the MEK inhibitor trametinib: a multicenter analysis. Blood Adv 7(15):3984–3992

4. Costelloe CM, Chuang HH, Madewell JE, Ueno NT (2010) Cancer response criteria and bone metastases: RECIST 1.1, MDA and PERCIST. J Cancer 1:80–92

5. Abeykoon JP, Rech KL, Young JR, Ravindran A, Ruan GJ, Dasari S et al (2022) Outcomes after treatment with cobimetinib in patients with Rosai-Dorfman disease based on KRAS and MEK alteration status. JAMA Oncol 8(12):1816–1820

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating monocytes decrease significantly following disease-directed therapy and may reflect disease expansion in Langerhans Cell Histiocytosis;Annals of Hematology;2024-08-27

2. Circulating monocytes decrease significantly following disease-directed therapy and may reflect disease expansion in Langerhans Cell Histiocytosis;2024-04-04

3. Erdheim–Chester Disease: Investigating the Correlation between Targeted Treatment Therapy and Disease Outcomes;Cancers;2024-03-27